An AI-native prognostic and predictive test for breast cancer that analyzes multi-modal patient data to assess disease aggressiveness and predict recurrence risk.

An AI foundation model trained on hundreds of millions of pan-cancer pathology slide images to extract tumor morphology features correlated with patient outcomes and treatment response.